News
ERNA
0.2490
+1.47%
0.0036
Weekly Report: what happened at ERNA last week (1216-1220)?
Weekly Report · 3d ago
Weekly Report: what happened at ERNA last week (1209-1213)?
Weekly Report · 12/16 10:28
Weekly Report: what happened at ERNA last week (1202-1206)?
Weekly Report · 12/09 10:26
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/04 21:06
Eterna launches research to evaluate ERNA-101
TipRanks · 12/03 13:36
ETERNA: TO INVESTIGATE ABILITY OF ERNA-101 TO INDUCE, MODULATE ANTITUMOR IMMUNITY IN OVARIAN CANCER, BREAST CANCER MODELS THROUGH RESEARCH
Reuters · 12/03 13:32
Weekly Report: what happened at ERNA last week (1125-1129)?
Weekly Report · 12/02 10:27
ETERNA THERAPEUTICS ANNOUNCES UP TO $1 MILLION STOCK REPURCHASE PROGRAM
Reuters · 11/25 13:30
Weekly Report: what happened at ERNA last week (1118-1122)?
Weekly Report · 11/25 10:22
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/19 11:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/18 21:05
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/18 15:15
Weekly Report: what happened at ERNA last week (1111-1115)?
Weekly Report · 11/18 10:20
Eterna Therapeutics Regains Nasdaq Compliance and Plans Advancements in Cell Therapy for Cancer Treatment
Barchart · 11/14 17:52
Eterna regains compliance with Nasdaq
TipRanks · 11/14 13:45
ETERNA THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ FOR CONTINUED LISTING
Reuters · 11/14 13:30
Weekly Report: what happened at ERNA last week (1104-1108)?
Weekly Report · 11/11 10:28
Eterna files to sell 49.87M shares of common stock for holders
TipRanks · 11/05 21:36
Weekly Report: what happened at ERNA last week (1028-1101)?
Weekly Report · 11/04 10:27
Eterna Therapeutics Completes Strategic Financial Restructuring, Reducing Its Liability By Discontinuing A Longstanding Lease, Resulting In An Estimated $72M In Savings And A Reduction Of ~$700,000 In Monthly Cash Outflow
Benzinga · 10/30 12:40
More
Webull provides a variety of real-time ERNA stock news. You can receive the latest news about Eterna Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About ERNA
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.